Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors

Bioorganic & Medicinal Chemistry Letters
2011.0

Abstract

Discovery of GR inhibitors has become very popular recently due to antimalarial and anticancer activities. In this study, the synthesis and GR inhibitory capacities of novel nitroaromatic compounds (NCs) (1-3) were reported. Some commercially available molecules were also tested for comparison reasons. The novel NCs were obtained in high yields using simple chemical procedures and exhibited much potent inhibitory activities against GR at low micromolar concentrations with K(i) values ranging from 0.211 to 4.57 μM as compared with well-known agents. Inhibition mechanism was assessed as being due to occlusion of the active site entrance by means of the NCs. Molecular docking results have shown that docking poses of ligands are able to construct binding interactions with the essential amino acids.

Knowledge Graph

Similar Paper

Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis, Biological Evaluation, and Docking Studies of N-Substituted Acetamidines as Selective Inhibitors of Inducible Nitric Oxide Synthase
Journal of Medicinal Chemistry 2009.0
Nitroaromatic Amino Acids as Inhibitors of Neuronal Nitric Oxide Synthase
Journal of Medicinal Chemistry 1998.0
Structure Mechanism Insights and the Role of Nitric Oxide Donation Guide the Development of Oxadiazole-2-Oxides as Therapeutic Agents against Schistosomiasis
Journal of Medicinal Chemistry 2009.0
5-Substituted Tetrazoles as Bioisosteres of Carboxylic Acids. Bioisosterism and Mechanistic Studies on Glutathione Reductase Inhibitors as Antimalarials
Journal of Medicinal Chemistry 2004.0
Synthesis and evaluation of novel aromatic substrates and competitive inhibitors of GABA aminotransferase
Bioorganic & Medicinal Chemistry Letters 2008.0
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation
ACS Medicinal Chemistry Letters 2020.0
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies
ACS Medicinal Chemistry Letters 2015.0
Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens
Bioorganic & Medicinal Chemistry 2010.0
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma
European Journal of Medicinal Chemistry 2018.0